During the WFH 2024 Annual Meeting of the General Assembly, Brian O’Mahony, Chief Executive of the Irish Haemophilia Society national member organization (NMO) moved to pass the motion, which was then voted on and ratified.
Here is the text of the motion:
“That grave concern was expressed over the decision by the World Health Organization (WHO) to place pathogen reduced cryoprecipitate and cryoprecipitate on the core Essential Medicines List, with safe and effective clotting factor concentrates relegated to the complementary medicines list. This will lead to morbidity and mortality. The General Assembly calls on the WHO to reverse this erroneous decision without further delay.”
To read “WFH statement: inclusion of cryoprecipitate in the WHO’s EML and EMLc” published in December 2023, please click here.